JCR Pharmaceuticals Co Ltd
TSE:4552
JCR Pharmaceuticals Co Ltd
Cash from Financing Activities
JCR Pharmaceuticals Co Ltd
Cash from Financing Activities Peer Comparison
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
J
|
JCR Pharmaceuticals Co Ltd
TSE:4552
|
Cash from Financing Activities
¥2.7B
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cash from Financing Activities
-¥302.8B
|
CAGR 3-Years
29%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cash from Financing Activities
-¥123.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cash from Financing Activities
-¥60.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
8%
|
CAGR 10-Years
2%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cash from Financing Activities
-¥139.3B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-32%
|
CAGR 10-Years
-20%
|
|
Astellas Pharma Inc
TSE:4503
|
Cash from Financing Activities
¥478.6B
|
CAGR 3-Years
53%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is JCR Pharmaceuticals Co Ltd's Cash from Financing Activities?
Cash from Financing Activities
2.7B
JPY
Based on the financial report for Dec 31, 2023, JCR Pharmaceuticals Co Ltd's Cash from Financing Activities amounts to 2.7B JPY.
What is JCR Pharmaceuticals Co Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
-32%
The average annual Cash from Financing Activities growth rates for JCR Pharmaceuticals Co Ltd have been -32% over the past three years .